Clinical Trials
All Clinical Trials - Page 26 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03809429Phase 3Completed
Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
Gonadorelin
- NCT03862716Phase 3Completed
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
Liraglutide
- NCT03544073Phase 3Withdrawn
GnRH Agonist at Embryo Transfer: IVF Outcomes
Gonadorelin
- NCT03899077Phase 2Unknown
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
Gonadorelin
- NCT03882970Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Tirzepatide
- NCT04356430Phase 2Unknown
Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer
Gonadorelin
- NCT03878381EARLY_Phase 1Completed
Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream
Argireline
- NCT03861039Phase 3Completed
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Tirzepatide
- NCT03891875Phase 2Completed
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
Elamipretide
- NCT03790865Phase 2/Phase 3Terminated
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Ghrp-6
- NCT03856632Phase 4Active Not Recruiting
Liraglutide Effect in Atrial Fibrillation
Liraglutide
- NCT03841630Phase 1Completed
A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
Retatrutide
- NCT03888157N/ACompleted
A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
Liraglutide
- NCT03743025Phase 4Terminated
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Dulaglutide
- NCT03856047Phase 2Completed
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
Cagrilintide
- NCT03883412Phase 4Unknown
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
Liraglutide
- NCT03642600Phase 4Completed
The Gut Microbiome in Women With Polycystic Ovary Syndrome
Liraglutide
- NCT03842202Phase 1Completed
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
Semaglutide
- NCT03835013N/ACompleted
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
Exenatide
- NCT06725693N/ARecruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
Exenatide
- NCT03668470Phase 2Completed
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
Dulaglutide
- NCT03826160N/ACompleted
Growth Hormone Dynamics and Cardiac Steatosis in HIV
Tesamorelin
- NCT03823339N/ACompleted
A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
Liraglutide
- NCT02789878Phase 2Completed
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer
Gonadorelin
- NCT04535960Phase 2Unknown
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
Liraglutide
- NCT03885297N/ACompleted
3mg Liraglutide for Overweight or Obesity
Liraglutide
- NCT03789578Phase 1Completed
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
Semaglutide
- NCT03375788Phase 2Completed
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Tesamorelin
- NCT03737240Phase 3Completed
IDegLira HIGH Trial
Liraglutide
- NCT03087032Phase 4Recruiting
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Liraglutide
- NCT04046822Phase 4Unknown
Effect of Liraglutide on Microbiome in Obesity
Liraglutide
- NCT03795701N/ACompleted
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
Liraglutide
- NCT03799198Phase 4Completed
Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
Liraglutide
- NCT04371991N/ACompleted
Kisspeptin Levels in Early Pregnancy
Kisspeptin
- NCT03659682Phase 2Unknown
GLP1R in Parkinson's Disease
Semaglutide
- NCT03590626N/ACompleted
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Dulaglutide
- NCT03959865N/AUnknown
GLP-1 REceptor Agonists and Real World EvIdeNce
Liraglutide
- NCT04174378N/ACompleted
Luteal Phase Support In IVF Women Using GnRH Agonist
Gonadorelin
- NCT03712098Phase 2Completed
Daily Liraglutide for Nicotine Dependence
Liraglutide
- NCT03757130Phase 1Completed
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
Liraglutide
- NCT03730662Phase 3Completed
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Tirzepatide
- NCT04190160N/ACompleted
Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
Liraglutide
- NCT04428684Phase 1Completed
COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg
Gonadorelin
- NCT03574597Phase 3Completed
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Semaglutide
- NCT03724981Phase 4Completed
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Semaglutide
- NCT03292315Phase 4Completed
Once Weekly GLP-1 in Persons With Spinal Cord Injury
Semaglutide
- NCT03689374Phase 3Completed
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
Semaglutide
- NCT03993132N/ACompleted
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Liraglutide
- NCT03707171Phase 3Completed
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03480022Phase 3Completed
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
Liraglutide